Detalhe da pesquisa
1.
Applications of the partial-order continual reassessment method in the early development of treatment combinations.
Clin Trials
; : 17407745241234634, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554038
2.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855051
3.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
4.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
5.
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Curr Oncol Rep
; 23(9): 102, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269910
6.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
7.
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Blood
; 132(23): 2446-2455, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287523
8.
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma.
Br J Haematol
; 184(4): 524-535, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575016
9.
CNS prophylaxis in DLBCL: first do no harm.
Blood
; 139(16): 2420-2421, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35446381
10.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
11.
Orbital mantle cell lymphoma presenting as myasthenia gravis.
Orbit
; 36(6): 365-369, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28820310
12.
The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.
Curr Treat Options Oncol
; 16(6): 28, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975444
13.
Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes.
Ophthalmology
; 121(1): 334-341, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144449
14.
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).
Blood Cancer Discov
; 5(1): 21-33, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983485
15.
The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways.
Br J Haematol
; 163(1): 72-80, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23889282
16.
Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
Ophthalmology
; 120(9): 1915-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23664470
17.
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Blood Rev
; 61: 101101, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258362
18.
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis.
J Clin Invest
; 133(13)2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166997
19.
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Blood Adv
; 7(13): 2983-2993, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809796
20.
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma.
Blood Adv
; 6(5): 1490-1498, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34700344